Uso do bevacizumab (Avastin®) na síndrome KID: relato de caso

Caye, Luiza Müller; Scheid, Karin Linck; Pizzol, Melissa Manfroi Dal; Freda, Roberto

doi:10.1590/s0004-27492010000300015

Cited by 5 publications

(2 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Bilateral corneal pannus and neovascularisation is observed. Although the general prognosis of KID syndrome appears to be favorable, 1,26 but exanthema may persist over the lifetime, 1 early and long-term multidisciplinary monitoring of affected individuals is necessary. 26 Attention should be paid to increased susceptibility to infections and increased risk of developing malignant tumors, 1,26 particularly squamous cell carcinoma.…”

Section: Examination and Treatmentmentioning

confidence: 99%

“…Medical and surgical ocular interventions have demonstrated limited success in KID syndrome. Therapies have included artificial tears, corticosteroids, cyclosporine A, antibiotics, 2 subconjunctival bevacizumab in early stages could prevent corneal neovascularization, 2,26 penetrating keratoplasty, superficial keratectomy, removal of corneal pannus, corneal grafts, ocular surface stem cell transplantation, and keratoprosthesis implantation 2 …”

Section: Examination and Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Clinical, etiopathogenic, and therapeutic aspects ofKIDsyndrome

Cammarata‐Scalisi

Willoughby

Tadich

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

show abstract

Section: Examination and Treatmentmentioning

confidence: 99%

Section: Examination and Treatmentmentioning

confidence: 99%

Clinical, etiopathogenic, and therapeutic aspects ofKIDsyndrome

Cammarata‐Scalisi

Willoughby

Tadich

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

show abstract

Keratitis, ichthyosis, and deafness (KID) syndrome: A review of infectious and neoplastic complications

Coggshall¹,

Farsani²,

Ruben³

et al. 2013

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

Successfully Improving Visual Acuity in Keratitis–Ichthyosis–Deafness Syndrome Utilizing Gas-Permeable Lenses: A Case Report

Strul

Straughn

2018

Eye &Amp; Contact Lens: Science &Amp; Clinical Practice

View full text Add to dashboard Cite

There is currently no well-defined guideline for treatment and management of patients with keratitis-ichthyosis-deafness (KID) syndrome, and most patients will face disabling vision loss due to corneal neovascularization and cicatrization. We offer this case as an example of how we can improve visual acuity (VA) and quality of life even in advanced cases of corneal neovascularization. We showcase the use of gas-permeable (GP) contact lenses to provide useful, functional VA in a patient with long-standing visual impairment secondary to corneal neovascularization and irregularity due to KID syndrome. The patient's VA improved from 20/200 both eyes (OU) to 20/40 OU with successful fitting of GP lenses, which additionally relieved the patient's otherwise intractable monocular diplopia.

show abstract

Uso do bevacizumab (Avastin®) na síndrome KID: relato de caso

Cited by 5 publications

References 12 publications

Clinical, etiopathogenic, and therapeutic aspects ofKIDsyndrome

Clinical, etiopathogenic, and therapeutic aspects ofKIDsyndrome

Keratitis, ichthyosis, and deafness (KID) syndrome: A review of infectious and neoplastic complications

Successfully Improving Visual Acuity in Keratitis–Ichthyosis–Deafness Syndrome Utilizing Gas-Permeable Lenses: A Case Report

Contact Info

Product

Resources

About